Furthermore, a 12-month follow-up randomized control trial revealed that inflammatory chemokines and cytokines which are related to DM development [36], such as monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor alpha (TNF-α), were significantly reduced in the pitavastatin group than in the atorvastatin group [37]. The gene discussed is CCL2; the disease is diabetes mellitus.